Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes

BACKGROUND: PRAME (preferentially expressed antigen in melanoma), a member of the cancer-testis antigen family, has been shown to have increased expression in solid tumors, including sarcoma, and PRAME-specific therapies are currently in development for other cancers such as melanoma. METHODS: To ma...

詳細記述

保存先:
書誌詳細
出版年:Clin Sarcoma Res
主要な著者: Roszik, Jason, Wang, Wei-Lien, Livingston, John A., Roland, Christina L., Ravi, Vinod, Yee, Cassian, Hwu, Patrick, Futreal, Andrew, Lazar, Alexander J., Patel, Shreyaskumar R., Conley, Anthony P.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5471883/
https://ncbi.nlm.nih.gov/pubmed/28630682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-017-0077-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料